reports
ALSTOM S.A : Alstom va livrer le premier métro de Belgrade : une étape...
ALSTOM S.A : Alstom va livrer le premier métro de Belgrade : une étape historique pour la mobilité urbaine et la croissance économique de la capitale serbe Alstom fournira une solution de métro clé en main entièrement intégrée, comprenant 32 rames MetropolisCe projet urbain phare, d'une valeur de 915 millions d'euros1 soutiendra durablement la croissance, la connectivité et les ambitions climatiques de la Serbie 27 mars 2026 – Alstom, leader mondial de la mobilité intelligente et durable, a remporté un contrat clé en main de 915 millions d’euros pour la livraison de la ligne 1 du métro de...
ALSTOM S.A: Alstom to deliver Belgrade’s first metro: A historic leap ...
ALSTOM S.A: Alstom to deliver Belgrade’s first metro: A historic leap in urban mobility and economic growth Alstom will deliver a fully integrated, turnkey metro solution, including 32 Metropolis trainsThis flagship urban project valued at €915 million[1] will support Serbia’s long-term growth, connectivity and climate ambitions 27 March 2026 – Alstom, a global leader in smart and sustainable mobility, has secured a €915 million turnkey contract to deliver Belgrade’s Metro Line 1, the first fully automated metro system in Serbia. This project, connecting in the first phase Makiško Polje t...
Sportradar Files Its Annual Report on Form 20-F
Sportradar Files Its Annual Report on Form 20-F ST. GALLEN, Switzerland, March 27, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (the “Company”) today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on March 27, 2026. The annual report on Form 20-F can be accessed on the Company’s investor relations website at or on the SEC’s website at . The Company will provide a paper copy of the annual report containing its audited consolidated financial statements, free of charge, to its sh...
Roche Holding AG: 1 director
A director at Roche Holding AG sold 3,851 shares at 322.400CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Joan Sehim
Sealed Air : Issuance Focus
Sealed Air is tapping the primary market to finance the LBO by CD&R announced last November. As part of the $ 7.2bn financing package, the company plans to issue a single euro-denominated tranche, equivalent to $ 600m, maturing in 2033 (7NC3). The issue will be rated B1/B+ and will be a major test for the market.
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study ...
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer On track to share data from first two dose levels in 2H 2026 Targeting KLK3 and leveraging the dual emission of Tb161 represents an innovative approach for radiotherapies in Prostate Cancer Preclinical proof-of-concept mouse xenografts demonstrated RAD 402’s strong tumor targeting with minimal bone/marrow uptake and expected hepatic clearance SYDNEY, March 27, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceu...
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financ...
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates Company continues to evaluate strategic options to maximize shareholder value WATERTOWN, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today provided a business update and reported financial...
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financi...
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates AUCATZYL® (obecabtagene autoleucel) net product revenue of $23.3 million* for the fourth quarter of 2025 and $74.3 million* for the full year of 2025AUCATZYL® UK launch underway following successful National Institute for Health and Care Excellence (NICE) evaluationAutolus continues to expect full year 2026 AUCATZYL® net product revenue of $120 million to $135 million and shift to positive gross margin to occur in 2026Independent real-world AUCATZYL® data from ROCCA consortium confirm high...
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results ...
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year - - Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia - - Submitted of a Marketing Authorization Application with the Israel Ministry of Health - - U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels - - Major milestone upcoming: T...
Legence Reports Fourth Quarter and Year End 2025 Financial Results
Legence Reports Fourth Quarter and Year End 2025 Financial Results Record Quarterly Revenues of $737.6 Million, a 34.6% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 53% from Prior Year1 Record Total Backlog and Awards of $3.7 Billion, 49% Increase from a Year Ago, with Robust Q4 Book-to-Bill of 1.9x Tuck-In Acquisition of Seattle Area-Based Engineering Firm Establish First Quarter 2026 Guidance for Revenue of $925 Million - $950 Million and Non-GAAP Adjusted EBITDA of $90 Million - $100 Million Raise Full Year 2026 Guidance for Revenue to $3.7 Billion - $3.9 ...
Satellos Reports 2025 Financial Results and Highlights Recent Company ...
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker “MSLE” on Feb. 6, 2026 Secured global regulatory clearances and initiated BASECAMP, a placebo-controlled Phase 2 clinical trial of SAT-3247 in boys aged 7 to less than 10 years living with Duchenne muscular dystrophy (“Duchenne” or “DMD”) Presented initial functional outcomes from 56 days of treatment in TRAILHEAD (follow-on trial to CL-101) at the 2026 Muscular Dystrophy Association (MDA) Clinical & Sci...
Hudbay Provides Annual Reserve and Resource Update with Mine Life Exte...
Hudbay Provides Annual Reserve and Resource Update with Mine Life Extensions and Improved Three-Year Production Outlook TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today released its annual mineral reserve and resource update and issued new three-year production guidance. All amounts are in U.S. dollars, unless otherwise noted. Affirmed 2026 production guidance and issued new 2027 and 2028 production guidance, demonstrating increased copper and strong gold production from Hudbay’s stable operating platform with three long-...
Tulikivi Corporation’s annual report for 2025 has been published
Tulikivi Corporation’s annual report for 2025 has been published TULIKIVI CORPORATION STOCK EXCHANGE RELEASE 27 MARCH 2026 AT 13:00 The Tulikivi Corporation annual report for 2025 includes the company's financial statements for 2025 and the auditors' report, the Board of Directors' report, the corporate governance statement and the remuneration report. Tulikivi Corporation has published its financial statements in the XHTML format compliant with the European Single Electronic Format (ESEF) reporting requirements. In accordance with the ESEF requirements, the main statements in the consol...
Tulikivi Oyj:n vuoden 2025 vuosikertomus on julkaistu
Tulikivi Oyj:n vuoden 2025 vuosikertomus on julkaistu TULIKIVI OYJ PÖRSSITIEDOTE 27.3.2026 KLO 13:00 Tulikivi Oyj vuoden 2025 vuosikertomus sisältää yhtiön vuoden 2025 tilinpäätöksen ja tilintarkastuskertomuksen, hallituksen toimintakertomuksen, selvityksen hallinto- ja ohjausjärjestelmästä sekä palkitsemisraportin. Tulikivi Oyj on julkaissut tilinpäätöksen European Single Electronic Format (ESEF) raportointivaatimusten mukaisessa XHTML-muodossa. ESEF-vaatimusten mukaisesti konsernitilinpäätöksen päälaskelmat ja liitetiedot on merkitty XBRL-merkeillä. Tilintarkastaja on toimittanut varme...
DoubleDown Interactive Announces Results of 2026 Annual General Meetin...
DoubleDown Interactive Announces Results of 2026 Annual General Meeting SEOUL, South Korea, March 27, 2026 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, today announced that at its annual general meeting of shareholders held on March 27, 2026 at 11:00 a.m., Korea Standard Time (March 26, 2026 at 10:00 p.m., U.S. Eastern Time) in Seoul, Korea, the following actions were taken by the shareholders of record as of December 31, 2025 on the proposed resolut...
Aurora Mobile Partners with Soochow Securities to Advance Digital Tran...
Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform SHENZHEN, China, March 27, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced that it has entered a partnership with Soochow Securities Co., Ltd. (“Soochow Securities”). Through this partnership, Soochow Securities has adopted Aurora Mobile’s intelligent push notification solution, JPush. The rapid advancement of financial techno...
SFL - Notice of Annual General Meeting 2026
SFL - Notice of Annual General Meeting 2026 SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) advises that the 2026 Annual General Meeting of the Company will be held on May 11, 2026. The record date for voting at the Annual General Meeting is set to April 1, 2026. A copy of the Notice of Annual General Meeting and associated information, including the Company’s Annual Report on Form 20-F, will be distributed and made available on the Company’s website at prior to the meeting. March 27, 2026 The Board of DirectorsSFL Corporation Ltd.Hamilton, Bermuda About SFL SFL has a unique ...
ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Gro...
ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025 KFAR SABA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today issued a Letter to Shareholders from Ariel Aron, Chief Executive Officer. Dear Shareholders and Partners, 2025 will be remembered as a transformative year and a significant strategic turning point for ParaZero. I am writing to you to...
OTC Markets Group Welcomes Orvana Minerals Corp. to OTCQX
OTC Markets Group Welcomes Orvana Minerals Corp. to OTCQX NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (TSX: ORV; OTCQX: ORVMF), a multi-mine gold-copper-silver company, has qualified to trade on the OTCQX® Best Market. Orvana Minerals Corp. upgraded to OTCQX from the Pink Limited™ Market. Orvana Minerals Corp. begins trading today on OTCQX under the symbol “ORVMF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . ...
BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Ov...
BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Over RMB500 million in 2026 BEIJING, March 27, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB23.6 million to repurchase 506,252 ordinary shares on March 26. Year-to-date in 2026, the Company has deployed over RMB500 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. CONTACT: PIACENTE·FINANCIAL COMMUNICATIONS
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.